Cargando…
Abstract 118: Primary hyperaldosteronism presenting as subarachnoid hemorrhage
Background: Primary hyperaldosteronism (PA) develops due to abnormality in the zona glomerulosa of the adrenal gland which results in excessive production of aldosterone. Primary hyperaldosteronism remains an important cause of secondary hypertension. Subarachnoid hemorrhage is a pathological condit...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9067824/ http://dx.doi.org/10.4103/2230-8210.342243 |
_version_ | 1784700093317775360 |
---|---|
author | Panikar, Krish Ganesh1, H K |
author_facet | Panikar, Krish Ganesh1, H K |
author_sort | Panikar, Krish |
collection | PubMed |
description | Background: Primary hyperaldosteronism (PA) develops due to abnormality in the zona glomerulosa of the adrenal gland which results in excessive production of aldosterone. Primary hyperaldosteronism remains an important cause of secondary hypertension. Subarachnoid hemorrhage is a pathological condition in which the blood enters the subarachnoid space. Case Presentation: A 32 year old female presented with complains of uncontrolled hypertension on antihypertensive drugs. She gives history of a subarachnoid hemorrhage Examination revealed a BP of 170/100 mmhg which was not controlled on antihypertensive agents. Blood test showed a potassium level of 2.7 mmol/l [3.5-5 mmol/l], creatinine 0.9 mg/dl [0.7-1.4], Hb 10.5 gm/dl on the basis of the preliminary blood tests a serum Aldosterone levels were asked which showed 23.7 ng/dl [2-9 ng/dl] A CECT abdomen was done which revealed a lesion in the medial limb of the right adrenal gland. Conclusion: Primary hyperaldosteronism is an under diagnosed entity and has a higher mortality and morbidity when compared to individuals with essential hypertension. PA should be suspected in all individuals with resistant hypertension even those on multiple drugs and who develop hypokalemia. |
format | Online Article Text |
id | pubmed-9067824 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-90678242022-05-05 Abstract 118: Primary hyperaldosteronism presenting as subarachnoid hemorrhage Panikar, Krish Ganesh1, H K Indian J Endocrinol Metab Abstracts … Esicon 2021 Background: Primary hyperaldosteronism (PA) develops due to abnormality in the zona glomerulosa of the adrenal gland which results in excessive production of aldosterone. Primary hyperaldosteronism remains an important cause of secondary hypertension. Subarachnoid hemorrhage is a pathological condition in which the blood enters the subarachnoid space. Case Presentation: A 32 year old female presented with complains of uncontrolled hypertension on antihypertensive drugs. She gives history of a subarachnoid hemorrhage Examination revealed a BP of 170/100 mmhg which was not controlled on antihypertensive agents. Blood test showed a potassium level of 2.7 mmol/l [3.5-5 mmol/l], creatinine 0.9 mg/dl [0.7-1.4], Hb 10.5 gm/dl on the basis of the preliminary blood tests a serum Aldosterone levels were asked which showed 23.7 ng/dl [2-9 ng/dl] A CECT abdomen was done which revealed a lesion in the medial limb of the right adrenal gland. Conclusion: Primary hyperaldosteronism is an under diagnosed entity and has a higher mortality and morbidity when compared to individuals with essential hypertension. PA should be suspected in all individuals with resistant hypertension even those on multiple drugs and who develop hypokalemia. Wolters Kluwer - Medknow 2022-03 /pmc/articles/PMC9067824/ http://dx.doi.org/10.4103/2230-8210.342243 Text en Copyright: © 2022 Indian Journal of Endocrinology and Metabolism https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Abstracts … Esicon 2021 Panikar, Krish Ganesh1, H K Abstract 118: Primary hyperaldosteronism presenting as subarachnoid hemorrhage |
title | Abstract 118: Primary hyperaldosteronism presenting as subarachnoid hemorrhage |
title_full | Abstract 118: Primary hyperaldosteronism presenting as subarachnoid hemorrhage |
title_fullStr | Abstract 118: Primary hyperaldosteronism presenting as subarachnoid hemorrhage |
title_full_unstemmed | Abstract 118: Primary hyperaldosteronism presenting as subarachnoid hemorrhage |
title_short | Abstract 118: Primary hyperaldosteronism presenting as subarachnoid hemorrhage |
title_sort | abstract 118: primary hyperaldosteronism presenting as subarachnoid hemorrhage |
topic | Abstracts … Esicon 2021 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9067824/ http://dx.doi.org/10.4103/2230-8210.342243 |
work_keys_str_mv | AT panikarkrish abstract118primaryhyperaldosteronismpresentingassubarachnoidhemorrhage AT ganesh1hk abstract118primaryhyperaldosteronismpresentingassubarachnoidhemorrhage |